Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021

Upgrades

Citigroup upgraded the previous rating for Thor Industries Inc (NYSE:THO) from Neutral to Buy. For the third quarter, Thor Industries had an EPS of $3.29, compared to year-ago quarter EPS of $0.43. The current stock performance of Thor Industries shows a 52-week-high of $152.20 and a 52-week-low of $78.64. Moreover, at the end of the last trading period, the closing price was at $113.00.

According to Northcoast Research, the prior rating for Tractor Supply Co (NASDAQ:TSCO) was changed from Neutral to Buy. In the first quarter, Tractor Supply showed an EPS of $1.55, compared to $0.71 from the year-ago quarter. The stock has a 52-week-high of $200.75 and a 52-week-low of $127.78. At the end of the last trading period, Tractor Supply closed at $186.06.

According to Loop Capital, the prior rating for Cabot Corp (NYSE:CBT) was changed from Hold to Buy. For the second quarter, Cabot had an EPS of $1.38, compared to year-ago quarter EPS of $0.77. At the moment, the stock has a 52-week-high of $65.25 and a 52-week-low of $34.84. Cabot closed at $56.93 at the end of the last trading period.

According to Citigroup, the prior rating for Meritor Inc (NYSE:MTOR) was changed from Neutral to Buy. In the second quarter, Meritor showed an EPS of $0.68, compared to $0.74 from the year-ago quarter. The current stock performance of Meritor shows a 52-week-high of $33.56 and a 52-week-low of $18.16. Moreover, at the end of the last trading period, the closing price was at $23.42.

For WideOpenWest Inc (NYSE:WOW), Raymond James upgraded the previous rating of Market Perform to Strong Buy. WideOpenWest earned $0.11 in the first quarter, compared to $0.08 in the year-ago quarter. The stock has a 52-week-high of $21.34 and a 52-week-low of $4.72. At the end of the last trading period, WideOpenWest closed at $20.71.

HC Wainwright & Co. upgraded the previous rating for Aspen Aerogels Inc (NYSE:ASPN) from Neutral to Buy. Aspen Aerogels earned $0.22 in the first quarter, compared to $0.13 in the year-ago quarter. The current stock performance of Aspen Aerogels shows a 52-week-high of $31.00 and a 52-week-low of $5.78. Moreover, at the end of the last trading period, the closing price was at $29.92.

Deutsche Bank upgraded the previous rating for Celanese Corp (NYSE:CE) from Hold to Buy. Celanese earned $3.46 in the first quarter, compared to $2.29 in the year-ago quarter. The stock has a 52-week-high of $171.00 and a 52-week-low of $83.09. At the end of the last trading period, Celanese closed at $151.60.

According to Wells Fargo, the prior rating for First Hawaiian Inc (NASDAQ:FHB) was changed from Underweight to Equal-Weight. First Hawaiian earned $0.44 in the first quarter, compared to $0.30 in the year-ago quarter. The current stock performance of First Hawaiian shows a 52-week-high of $30.80 and a 52-week-low of $14.15. Moreover, at the end of the last trading period, the closing price was at $28.34.

For Ascential PLC (OTC:AIAPF), Berenberg upgraded the previous rating of Hold to Buy. The current stock performance of Ascential shows a 52-week-high of $6.00 and a 52-week-low of $5.60. Moreover, at the end of the last trading period, the closing price was at $5.81.

Berenberg upgraded the previous rating for NCC Group PLC (OTC:NCCGF) from Hold to Buy. The stock has a 52-week-high of $4.08 and a 52-week-low of $2.31. At the end of the last trading period, NCC Group closed at $4.08.

Credit Suisse upgraded the previous rating for AGCO Corp (NYSE:AGCO) from Neutral to Outperform. In the first quarter, AGCO showed an EPS of $2.00, compared to $0.86 from the year-ago quarter. The stock has a 52-week-high of $158.62 and a 52-week-low of $52.36. At the end of the last trading period, AGCO closed at $130.38.

For Heartland Express Inc (NASDAQ:HTLD), JP Morgan upgraded the previous rating of Neutral to Overweight. Heartland Express earned $0.17 in the first quarter, compared to $0.16 in the year-ago quarter. The stock has a 52-week-high of $22.75 and a 52-week-low of $16.69. At the end of the last trading period, Heartland Express closed at $17.13.

For Enbridge Inc (NYSE:ENB), Goldman Sachs upgraded the previous rating of Sell to Neutral. In the first quarter, Enbridge showed an EPS of $0.64, compared to $0.62 from the year-ago quarter. At the moment, the stock has a 52-week-high of $41.13 and a 52-week-low of $26.97. Enbridge closed at $40.04 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

For Polaris Inc (NYSE:PII), Longbow Research downgraded the previous rating of Buy to Neutral. Polaris earned $2.30 in the first quarter, compared to $0.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $147.73 and a 52-week-low of $86.67. Polaris closed at $136.96 at the end of the last trading period.

For Bioventus Inc (NASDAQ:BVS), Goldman Sachs downgraded the previous rating of Buy to Neutral. Bioventus earned $0.15 in the first quarter. The current stock performance of Bioventus shows a 52-week-high of $19.94 and a 52-week-low of $10.74. Moreover, at the end of the last trading period, the closing price was at $17.60.

Deutsche Bank downgraded the previous rating for BNP Paribas (OTC:BNPQY) from Buy to Hold. At the moment, the stock has a 52-week-high of $35.31 and a 52-week-low of $16.78. BNP Paribas closed at $31.32 at the end of the last trading period.

According to Jefferies, the prior rating for Partners Group Holding AG (OTC:PGPHF) was changed from Buy to Hold. At the moment, the stock has a 52-week-high of $1590.00 and a 52-week-low of $899.20. Partners Group Holding closed at $1510.20 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

For Aspirational Consumer Lifestyle Corp (NYSE:ASPL), Barrington Research initiated coverage, by setting the current rating at Outperform. At the moment, the stock has a 52-week-high of $11.75 and a 52-week-low of $9.65. Aspirational Consumer closed at $9.98 at the end of the last trading period.

CL King initiated coverage on Atotech Ltd (NYSE:ATC) with a Neutral rating. Interestingly, in the first quarter, Atotech's EPS was $0.55. The stock has a 52-week-high of $26.67 and a 52-week-low of $17.00. At the end of the last trading period, Atotech closed at $25.53.

Cantor Fitzgerald initiated coverage on Latch Inc (NASDAQ:LTCH) with an Overweight rating. The price target for Latch is set to $19.00. At the moment, the stock has a 52-week-high of $13.17 and a 52-week-low of $10.26. Latch closed at $12.27 at the end of the last trading period.

JMP Securities initiated coverage on Taboola.com Ltd (NASDAQ:TBLA) with a Market Outperform rating. The price target for Taboola.com is set to $17.00. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Taboola.com closed at $10.35.

Piper Sandler initiated coverage on CareMax Inc (NASDAQ:CMAX) with a Neutral rating. The price target for CareMax is set to $14.00. The current stock performance of CareMax shows a 52-week-high of $15.91 and a 52-week-low of $12.21. Moreover, at the end of the last trading period, the closing price was at $12.90.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Upgrades

For American Axle & Mfg Holdings Inc (NYSE:AXL), Keybanc upgraded the previous rating of Sector Weight to Overweight. American Axle & Mfg Hldgs earned $0.57 in the first quarter, compared to $0.20 in the year-ago quarter. The stock has a 52-week-high of $13.05 and a 52-week-low of $4.82. At the end of the last trading period, American Axle & Mfg Hldgs closed at $10.35.

See all analyst ratings upgrades.

Downgrades

Summit Insights Group downgraded the previous rating for Micron Technology Inc (NASDAQ:MU) from Buy to Hold. In the third quarter, Micron Technology showed an EPS of $1.88, compared to $0.82 from the year-ago quarter. The current stock performance of Micron Technology shows a 52-week-high of $96.96 and a 52-week-low of $42.25. Moreover, at the end of the last trading period, the closing price was at $84.98.

According to Berenberg, the prior rating for bluebird bio Inc (NASDAQ:BLUE) was changed from Buy to Hold. In the first quarter, bluebird bio showed an EPS of $3.07, compared to $3.64 from the year-ago quarter. The current stock performance of bluebird bio shows a 52-week-high of $68.39 and a 52-week-low of $24.24. Moreover, at the end of the last trading period, the closing price was at $31.98.

B of A Securities downgraded the previous rating for Ventas Inc (NYSE:VTR) from Buy to Neutral. In the first quarter, Ventas showed an EPS of $0.72, compared to $0.97 from the year-ago quarter. The current stock performance of Ventas shows a 52-week-high of $59.75 and a 52-week-low of $33.82. Moreover, at the end of the last trading period, the closing price was at $57.10.

According to BTIG, the prior rating for New Senior Investment Group Inc (NYSE:SNR) was changed from Buy to Neutral. For the first quarter, New Senior Investment Gr had an EPS of $0.11, compared to year-ago quarter EPS of $0.16. The current stock performance of New Senior Investment Gr shows a 52-week-high of $8.99 and a 52-week-low of $3.02. Moreover, at the end of the last trading period, the closing price was at $8.78.

Berenberg downgraded the previous rating for Sensei Biotherapeutics Inc (NASDAQ:SNSE) from Buy to Hold. Sensei Biotherapeutics earned $0.42 in the first quarter, compared to $4.00 in the year-ago quarter. The current stock performance of Sensei Biotherapeutics shows a 52-week-high of $26.50 and a 52-week-low of $9.00. Moreover, at the end of the last trading period, the closing price was at $9.76.

For Goosehead Insurance Inc (NASDAQ:GSHD), JP Morgan downgraded the previous rating of Overweight to Neutral. For the first quarter, Goosehead Insurance had an EPS of $0.03, compared to year-ago quarter EPS of $0.00. At the moment, the stock has a 52-week-high of $174.79 and a 52-week-low of $72.35. Goosehead Insurance closed at $127.30 at the end of the last trading period.

Credit Suisse downgraded the previous rating for RISE Education Cayman Ltd (NASDAQ:REDU) from Outperform to Neutral. For the first quarter, RISE Education Cayman had an EPS of $0.05, compared to year-ago quarter EPS of $0.25. The current stock performance of RISE Education Cayman shows a 52-week-high of $10.20 and a 52-week-low of $2.55. Moreover, at the end of the last trading period, the closing price was at $2.61.

For Edison International (NYSE:EIX), Keybanc downgraded the previous rating of Overweight to Sector Weight. In the first quarter, Edison showed an EPS of $0.79, compared to $0.63 from the year-ago quarter. The current stock performance of Edison shows a 52-week-high of $66.68 and a 52-week-low of $48.47. Moreover, at the end of the last trading period, the closing price was at $57.82.

See all analyst ratings downgrades.

Initiations

Noble Capital Markets initiated coverage on Flotek Industries Inc (NYSE:FTK) with an Outperform rating. The price target for Flotek Industries is set to $2.50. For the first quarter, Flotek Industries had an EPS of $0.12, compared to year-ago quarter EPS of $0.19. At the moment, the stock has a 52-week-high of $3.09 and a 52-week-low of $1.17. Flotek Industries closed at $1.73 at the end of the last trading period.

Maxim Group initiated coverage on Stealth BioTherapeutics Corp (NASDAQ:MITO) with a Buy rating. The price target for Stealth BioTherapeutics is set to $3.00. For the first quarter, Stealth BioTherapeutics had an EPS of $0.01, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $2.58 and a 52-week-low of $1.06. Stealth BioTherapeutics closed at $1.56 at the end of the last trading period.

Alliance Global Partners initiated coverage on Verastem Inc (NASDAQ:VSTM) with a Buy rating. The price target for Verastem is set to $6.00. Verastem earned $0.07 in the first quarter, compared to $0.20 in the year-ago quarter. The current stock performance of Verastem shows a 52-week-high of $4.93 and a 52-week-low of $1.08. Moreover, at the end of the last trading period, the closing price was at $4.07.

With a Buy rating, Argus Research initiated coverage on Qorvo Inc (NASDAQ:QRVO). The price target seems to have been set at $225.00 for Qorvo. In the fourth quarter, Qorvo showed an EPS of $2.74, compared to $1.57 from the year-ago quarter. The stock has a 52-week-high of $201.68 and a 52-week-low of $107.18. At the end of the last trading period, Qorvo closed at $195.65.

Barclays initiated coverage on ZipRecruiter Inc (NYSE:ZIP) with an Overweight rating. The price target for ZipRecruiter is set to $30.00. For the fourth quarter, ZipRecruiter had an EPS of $0.34, compared to year-ago quarter EPS of $0.09. The current stock performance of ZipRecruiter shows a 52-week-high of $25.57 and a 52-week-low of $19.32. Moreover, at the end of the last trading period, the closing price was at $24.98.

Guggenheim initiated coverage on Seelos Therapeutics Inc (NASDAQ:SEEL) with a Buy rating. The price target for Seelos Therapeutics is set to $8.00. Seelos Therapeutics earned $0.28 in the first quarter, compared to $0.14 in the year-ago quarter. At the moment, the stock has a 52-week-high of $6.60 and a 52-week-low of $0.56. Seelos Therapeutics closed at $2.64 at the end of the last trading period.

With a Neutral rating, Goldman Sachs initiated coverage on LivePerson Inc (NASDAQ:LPSN). The price target seems to have been set at $71.00 for LivePerson. LivePerson earned $0.31 in the first quarter, compared to $0.41 in the year-ago quarter. The current stock performance of LivePerson shows a 52-week-high of $72.23 and a 52-week-low of $37.10. Moreover, at the end of the last trading period, the closing price was at $63.24.

With a Buy rating, B. Riley Securities initiated coverage on Bed Bath & Beyond Inc (NASDAQ:BBBY). The price target seems to have been set at $44.00 for Bed Bath & Beyond. For the first quarter, Bed Bath & Beyond had an EPS of $0.05, compared to year-ago quarter EPS of $1.96. At the moment, the stock has a 52-week-high of $53.90 and a 52-week-low of $7.39. Bed Bath & Beyond closed at $33.29 at the end of the last trading period.

With an Outperform rating, Oppenheimer initiated coverage on AquaBounty Technologies Inc (NASDAQ:AQB). The price target seems to have been set at $7.00 for AquaBounty Technologies. In the first quarter, AquaBounty Technologies showed an EPS of $0.06, compared to $0.11 from the year-ago quarter. The current stock performance of AquaBounty Technologies shows a 52-week-high of $13.32 and a 52-week-low of $2.40. Moreover, at the end of the last trading period, the closing price was at $5.36.

With a Perform rating, Oppenheimer initiated coverage on OFS Capital Corp (NASDAQ:OFS). The price target seems to have been set at $10.00 for OFS Capital. For the first quarter, OFS Capital had an EPS of $0.23, compared to year-ago quarter EPS of $0.30. The stock has a 52-week-high of $10.30 and a 52-week-low of $3.96. At the end of the last trading period, OFS Capital closed at $9.96.

With an Outperform rating, Raymond James initiated coverage on Passage Bio Inc (NASDAQ:PASG). The price target seems to have been set at $29.00 for Passage Bio. Passage Bio earned $0.76 in the first quarter, compared to $1.00 in the year-ago quarter. The current stock performance of Passage Bio shows a 52-week-high of $30.87 and a 52-week-low of $12.10. Moreover, at the end of the last trading period, the closing price was at $13.24.

For Vertex Pharmaceuticals Inc (NASDAQ:VRTX), Raymond James initiated coverage, by setting the current rating at Market Perform. In the first quarter, Vertex Pharmaceuticals showed an EPS of $2.98, compared to $2.56 from the year-ago quarter. At the moment, the stock has a 52-week-high of $306.08 and a 52-week-low of $185.32. Vertex Pharmaceuticals closed at $201.63 at the end of the last trading period.

For Agios Pharmaceuticals Inc (NASDAQ:AGIO), Raymond James initiated coverage, by setting the current rating at Market Perform. Agios Pharmaceuticals earned $1.31 in the first quarter, compared to $0.59 in the year-ago quarter. At the moment, the stock has a 52-week-high of $62.16 and a 52-week-low of $32.47. Agios Pharmaceuticals closed at $55.11 at the end of the last trading period.

Daiwa Capital initiated coverage on Twilio Inc (NYSE:TWLO) with a Buy rating. The price target for Twilio is set to $463.00. Twilio earned $0.05 in the first quarter, compared to $0.06 in the year-ago quarter. The current stock performance of Twilio shows a 52-week-high of $457.30 and a 52-week-low of $208.95. Moreover, at the end of the last trading period, the closing price was at $394.16.

See all analyst ratings initiations.

AGCOAGCO Corp

$138.47-%

Overview

AGIOAgios Pharmaceuticals Inc

$28.261.98%

AQBAquaBounty Technologies Inc

$0.89762.00%

ASPNAspen Aerogels Inc

$3.51-%

AXL

$9.14-%